Oncogenic MYD88 Mutations Are Rare Events in Double-Hit B-Cell Lymphomas

Publisher： Karger

E-ISSN： 1421-9662|133|1|113-115

ISSN： 0001-5792

Source： Acta Haematologica, Vol.133, Iss.1, 2014-09, pp. : 113-115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinicopathological features of double‐hit B‐cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 10, 2015-10 ,pp. : 519-527

John Wiley & Sons Inc

Access to resources Recommend Favorite

Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 2, 2015-07 ,pp. : 285-287

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver fibrosis occurs through dysregulation of MyD88‐dependent innate B‐cell activity

By  

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 2067-2079

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B‐cell non‐Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 7, 2015-07 ,pp. : 413-420

John Wiley & Sons Inc

Access to resources Recommend Favorite

A clinician's guide to double hit lymphomas

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 6, 2015-03 ,pp. : 784-795

John Wiley & Sons Inc

Access to resources Recommend Favorite